UBS Group AG Reduces Holdings in Addus HomeCare Corporation $ADUS

UBS Group AG cut its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 23.5% in the 4th quarter, HoldingsChannel reports. The fund owned 59,314 shares of the company’s stock after selling 18,271 shares during the quarter. UBS Group AG’s holdings in Addus HomeCare were worth $6,370,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Hohimer Wealth Management LLC boosted its holdings in Addus HomeCare by 3.4% during the 3rd quarter. Hohimer Wealth Management LLC now owns 2,709 shares of the company’s stock valued at $320,000 after acquiring an additional 88 shares during the period. Amalgamated Bank lifted its holdings in Addus HomeCare by 1.8% in the 3rd quarter. Amalgamated Bank now owns 5,240 shares of the company’s stock worth $618,000 after buying an additional 93 shares during the period. CANADA LIFE ASSURANCE Co lifted its holdings in Addus HomeCare by 0.6% in the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 18,684 shares of the company’s stock worth $2,150,000 after buying an additional 106 shares during the period. Private Trust Co. NA lifted its holdings in Addus HomeCare by 65.5% in the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after buying an additional 112 shares during the period. Finally, Pathstone Holdings LLC lifted its holdings in Addus HomeCare by 0.9% in the 3rd quarter. Pathstone Holdings LLC now owns 12,727 shares of the company’s stock worth $1,502,000 after buying an additional 112 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, EVP David W. Tucker sold 704 shares of the firm’s stock in a transaction that occurred on Tuesday, February 24th. The stock was sold at an average price of $107.35, for a total transaction of $75,574.40. Following the completion of the transaction, the executive vice president owned 10,802 shares of the company’s stock, valued at $1,159,594.70. This trade represents a 6.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Brian Poff sold 2,041 shares of the firm’s stock in a transaction that occurred on Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total value of $218,346.18. Following the transaction, the executive vice president directly owned 64,512 shares of the company’s stock, valued at approximately $6,901,493.76. This trade represents a 3.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 16,788 shares of company stock worth $1,785,633 over the last quarter. Company insiders own 4.50% of the company’s stock.

Addus HomeCare Trading Down 0.1%

ADUS opened at $92.59 on Wednesday. The stock has a market cap of $1.73 billion, a PE ratio of 17.11, a PEG ratio of 1.27 and a beta of 0.92. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.08. The business has a 50 day moving average of $96.29 and a 200-day moving average of $105.90. Addus HomeCare Corporation has a 52 week low of $89.76 and a 52 week high of $124.43.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, May 4th. The company reported $1.62 EPS for the quarter, beating analysts’ consensus estimates of $1.52 by $0.10. The company had revenue of $363.50 million during the quarter, compared to analysts’ expectations of $366.41 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The firm’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.42 EPS. Equities research analysts predict that Addus HomeCare Corporation will post 6.24 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have weighed in on ADUS. Royal Bank Of Canada reiterated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Wednesday, February 25th. Stephens dropped their price objective on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. Barclays dropped their price objective on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating for the company in a report on Friday. KeyCorp reiterated an “overweight” rating on shares of Addus HomeCare in a report on Wednesday, February 25th. Finally, Wall Street Zen cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 21st. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Addus HomeCare has a consensus rating of “Moderate Buy” and an average price target of $131.22.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.